CONCLUSIONS: These results suggest that recombinant PEDF protein may abolish the development of characteristic features of chronic allergic asthma via VEGF suppression, providing a potential treatment option for chronic airway inflammation diseases such as asthma. PMID: 26739410 [PubMed] (Source: Allergy, Asthma and Immunology Research)
MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader http://ift.tt/1OWNr2T
via IFTTT
from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1Q6FYxl
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου